絞り込み

16645

広告

氷上のワカサギ釣り解禁 暖冬で10日遅れ 前橋 群馬

前橋市の、赤城山にある湖で冬の風物詩、氷上のワカサギ釣りが暖冬による影響で例年よりも10日ほど遅れて22日朝、解禁され多くの愛好家でにぎわっています。

  1. 新型ウイルス肺炎 死者9人 患者440人...
  2. 色々な色の名前、日本語と英語での名前、伝...
  3. 調達情報 企業啓発用ガイドブック201,...
  4. 調達情報 令和2年度~令和4年度診療報酬...

ニュース一覧

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

著者 Ageno W , Mantovani LG , Haas S , Kreutz R , Monje D , Schneider J , Bugge JP , Gebel M , Turpie AGG
TH Open.2019 Jan ; 3(1):e85-e93.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (352view , 0users)

Full Text Sources

Medical

 Overall, 30 to 50% of lower-limb deep-vein thrombosis (DVT) cases are isolated distal DVT (IDDVT). The recurrent venous thromboembolism (VTE) risk is unclear, leaving uncertainty over optimal IDDVT treatment. We present data on patients with IDDVT and proximal DVT (PDVT) from the prospective, noninterventional XALIA study of rivaroxaban for acute and extended VTE treatment.  Patients aged ≥18 years scheduled to receive ≥3 months' anticoagulation with rivaroxaban or standard anticoagulation were eligible, with follow-up for ≥12 months. We describe baseline characteristics, management strategies, and incidence proportions of VTE recurrence, major bleeding, and all-cause mortality in patients with IDDVT or PDVT, with or without distal vein involvement.  Overall, 1,004 patients with IDDVT and 3,098 with PDVT were enrolled; 641 (63.8%) and 1,683 (54.3%) received rivaroxaban, respectively. Patients with IDDVT were younger and had lower incidences of renal impairment, cancer, and unprovoked VTE than those with PDVT. On-treatment recurrence incidences for IDDVT versus PDVT were 1.0 versus 2.4% (adjusted hazard ratio [HR]: 0.56; 95% confidence interval [CI]: 0.29-1.08), and incidences posttreatment cessation were 1.1 versus 2.1% (adjusted HR: 0.65; 95% CI: 0.32-1.35), respectively. On-treatment major bleeding incidences were 0.9 versus 1.4% and mortality was 0.8 versus 2.2%, respectively. Median treatment duration in patients with IDDVT was shorter than in those with PDVT (102 vs. 192 days, respectively).  Patients with IDDVT had fewer comorbidities and were more frequently treated with rivaroxaban than those with PDVT. On-treatment and posttreatment recurrences were less frequent in patients with IDDVT.  NCT01619007.
PMID: 31249987 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード